YouTube: https://youtube.com/watch?v=rZhE2GcFid0
Previous: Exercise, Weight Loss, and Big Soda
Next: Data and Studies on Malpractice

Categories

Statistics

View count:20,842
Likes:688
Dislikes:4
Comments:40
Duration:07:38
Uploaded:2017-04-24
Last sync:2022-10-31 16:15
This week, we continue our series on Orphan Drugs by looking at a few ways that pharmaceutical companies game the system, and shoehorn their drugs into qualifying for orphan drug status, and therefore greater patent protection. All these methods tend to translate to higher costs for consumers.



Sources can be found in the posts friend-of-the-show Nick Bagley has written on the subject: http://theincidentaleconomist.com/wordpress/tag/orphan-drugs/">http://theincidentaleconomist.com/wordpress/tag/orphan-drugs/



John Green -- Executive Producer

Stan Muller -- Director, Producer

Aaron Carroll -- Writer

Mark Olsen – Graphics

Meredith Danko – Social Media



http://www.twitter.com/aaronecarroll">http://www.twitter.com/aaronecarroll

http://www.twitter.com/crashcoursestan">http://www.twitter.com/crashcoursestan

http://www.twitter.com/johngreen">http://www.twitter.com/johngreen

http://www.twitter.com/olsenvideo">http://www.twitter.com/olsenvideo



And the housekeeping:



1) You can support Healthcare Triage on Patreon: http://vid.io/xqXr">http://vid.io/xqXr Every little bit helps make the show better!

2) Check out our Facebook page: http://goo.gl/LnOq5z">http://goo.gl/LnOq5z

3) We still have merchandise available at http://www.hctmerch.com">http://www.hctmerch.com
No transcript to display.